65 -- Purchase of Mumps Kits

The Centers for Disease Control and Prevention plans to issue a sole source purchase order to Inverness Medical for mumps IgG kits, specifically to address a recent outbreak. Each kit must contain 480 tests, and all kits procured must originate from the same lot number to meet the requirements of the Clinical Laboratory Improvement Act (CLIA) proficiency testing for mumps. Compliance with CLIA regulations is mandatory for this procurement, ensuring the kits meet standardized quality and reliability criteria essential for clinical testing. This acquisition is justified under federal acquisition regulations FAR 6.302-1 and 6.302-2, as only Inverness Medical is deemed capable of fulfilling the agency’s specific needs, thus no competitive solicitation will be issued. Although the procurement is not set aside for small businesses, other interested parties may express their interest and capability to meet the requirements. For further information or contractual questions, Linda M. Young, the designated purchasing agent, is the contact person.